Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Kidney Medicine|August 1, 2020
SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case ReportKatherine M Wang, Robert T IsomSeminars in Dialysis|March 6, 2019
Timing of blood pressure medications and intradialytic hypotensionKatherine M Wang, Tammy L Sirich, Tara I ChangHypertension (Dallas, Tex. : 1979)|November 2, 2020
Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT)Katherine M Wang, Margaret R Stedman, Glenn M Chertow, et al.Journal of General Internal Medicine|May 6, 2024
Empagliflozin and Risk of Incident Gout: Analysis from the EMPagliflozin Comparative Effectiveness and SafEty (EMPRISE) Cohort StudyHelen Tesfaye, Katherine M Wang, Luke E Zabotka, et al.Endocrinology, Diabetes & Metabolism|July 19, 2021
Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS ProgramKatherine M Wang, JingWei Li, Vivek Bhalla, et al.Healthcare (Amsterdam, Netherlands)|November 8, 2021
Application of the Quadruple Aim to evaluate the operational impact of a telemedicine programNeil M Kalwani, Katherine M Wang, Austin N Johnson, et al.Journal for Immunotherapy of Cancer|July 1, 2025
ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignanciesKevin P Nishimoto, Gauri Lamture, Yvan Chanthery, et al.Pageof 1